EB-003

N/A

Report date: 2025/07/16 14:42:46

Base Information

Drug NameEB-003
Drug Alias NameEB-003
ClassificationBiologics > BacteriophagesCell and gene therapy > Gene therapy
Mechanisms of ActionDNA inhibitorsCell death stimulantsMicrobiome modulators
TargetsDNA
Therapy Area/IndicationsDiarrheaHemolytic-Uremic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEligo Bioscience
China Registration ClassN/A

Develop Information

Active CompaniesEligo Bioscience
Inactive CompaniesN/A
Active IndicationsDiarrheaHemolytic-Uremic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A